KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,189 | -20.0% | 84,447 | -38.9% | 0.00% | 0.0% |
| Q1 2023 | $1,487 | +48.8% | 138,180 | +107.2% | 0.00% | +100.0% |
| Q4 2022 | $999 | -99.9% | 66,700 | -45.2% | 0.00% | -50.0% |
| Q3 2022 | $1,564,000 | +199.0% | 121,800 | +125.6% | 0.00% | +100.0% |
| Q2 2022 | $523,000 | -66.8% | 54,000 | -66.0% | 0.00% | -50.0% |
| Q1 2022 | $1,577,000 | -55.8% | 158,700 | -47.7% | 0.00% | -50.0% |
| Q4 2021 | $3,570,000 | +1110.2% | 303,300 | +1716.2% | 0.00% | – |
| Q4 2020 | $295,000 | +22.4% | 16,700 | +6.4% | 0.00% | – |
| Q3 2020 | $241,000 | – | 15,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |